Frenkel Ran 4
4 · Karyopharm Therapeutics Inc. · Filed Feb 19, 2020
Insider Transaction Report
Form 4
Frenkel Ran
EVP, WW Development Operations
Transactions
- Exercise/Conversion
Restricted Stock Units
2020-02-15−9,675→ 29,025 total→ Common Stock (9,675 underlying) - Exercise/Conversion
Common Stock
2020-02-15+9,675→ 39,041 total
Footnotes (3)
- [F1]Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.
- [F2]Includes 4,633 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan.
- [F3]On February 15, 2019, the reporting person was granted 38,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on February 15, 2020. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any an event within 30 days of such date.